Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
General Rheumatology
•
SLE
What is your approach to management of recurrent Kikuchi-Fujimoto Disease?
Related Questions
What specific historical questions do you prioritize when evaluating hair loss to identify features suggestive of autoimmune or connective tissue disorders?
In what clinical situations do you consider azathioprine for treatment of inflammatory arthritis?
Does treatment with hydroxychloroquine increase the risk of hypertension or exacerbate pre-existing hypertension?
In an elderly male with recurrent unilateral exudative pleural effusion, +ANA 1:1280, homogeneous and +anti-Smith antibody, but no other lupus features, how do you decide between escalating immunosuppression versus pursuing pleurodesis?
Do you reduce the dose of hydroxychloroquine in patients with skin graying if they are not particularly bothered by this side effect?
How do you approach the use of immunosuppressive therapy in patients with rheumatoid arthritis and underlying immunodeficiency, such as IgA deficiency?
Are there specific combinations of DMARDs and/or biologics that you avoid due to elevated infection risk or other safety concerns?
At what level of renal impairment do you typically reduce or avoid methotrexate in your rheumatology practice?
How do you manage active psoriatic arthritis in a patient with a history of HIV and anal squamous cell carcinoma (post-radiation one year ago), previously treated with apremilast and sulfasalazine but has ongoing disease?
For patients who do not have access to biologic therapies, what are some csDMARD combination pearls or tips that you have that have particular efficacy in different rheumatologic diseases?
